Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Murat ÖZBALAK"'
Autor:
Murat Özbalak
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S3- (2023)
Follicular lymphoma (FL) is the most common non-Hodgkin lymphoma in the United States and Europe1. The disease is potentially incurable and, treatment options comprise a wide spectrum from local radiotherapy to chemoimmunotherapy, based on the risk f
Externí odkaz:
https://doaj.org/article/215ec6ee156842e180c905acaf0027f8
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S40- (2023)
Objective: Amyloid deposits can be localized as a wall thickness or mass lesion either as AA amyloidosis or AL amyloidosis and may develop nearly on all organs. It is generally a mild, non–life-threatening entity with a good prognosis and rarely sh
Externí odkaz:
https://doaj.org/article/d34667c4ef264074b0a5d43ecc4f61f1
Autor:
Murat Özbalak, Metban Mastanzade, Dilek Özden Özlük, Tarık Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, İpek Yçnal Hindilerden, Ali Yılmaz Altay, Gülçin Yeğen, Ahmet Emre Eşkazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoğlu Beşışık
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 4, Pp 254-261 (2022)
Objective: Redditux® (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera® (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lym
Externí odkaz:
https://doaj.org/article/2a9fff72faa5467abb4cb2fad80cdfb5
Autor:
Murat Özbalak
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S1-S2 (2022)
About 15% of classical Hodgkin lymphoma (cHL) patients remain refractory to first-line therapy and about one third of the responding patients relapse1. The standard of care for relapsed or refractory (R/R) cHL is salvage chemotherapy followed by high
Externí odkaz:
https://doaj.org/article/33b6b2094fb7447ab1777d8b97825389
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S33- (2021)
Objective: Asparaginase has a very important role in ALL treatment among increasing of remission rate and duration. Multiple side effects prevent its regulatory use. Asparaginase reduce antithrombin 3, heparin cofactor II, protein C and plasminogen s
Externí odkaz:
https://doaj.org/article/78145493b93d4c6f9cd9f42e79dff82c
Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature
Autor:
Besim Fazıl Ağargün, Murat Özbalak, Übeyde Ayşe Gülseren, Gülçin Yegen, Sevgi Kalayoğlu Beşışık
Publikováno v:
Hematology, Transfusion and Cell Therapy.
Autor:
Murat Özbalak, Işıl Erdoğan Özünal, Selin Berk, Tuğrul Elverdi, Ayşe Salihoğlu, Ahmet Emre Eşkazan, Ezgi Pınar Özbalak, Cem Ar, Şeniz Öngören, Zafer Başlar, Yıldız Aydın, Seda Ekizoğlu, Asuman Çelebi, Ayşe Nur Buyru, Teoman Soysal
Publikováno v:
İstanbul Tıp Fakültesi Dergisi. 84
Amac: Istanbul Universitesi Cerrahpasa Tip Fakultesi Hematoloji Poliklinigi’nde takip edilen 49 Kronik Lenfositik Losemi (KLL) hastasi calismaya dahil edilmistir. Calismanin amaci, cesitli otoimmun hastaliklar ile iliskisi gosterilmis olan Killer I
Publikováno v:
Experimed.
“Let food be thy medicine and let medicine be thy food.” This aphorism refers to the pivotal role played by nutrition in medicine. The door of a “nutrition renaissance” has been opened with the striking disclosure of the relationship between
Publikováno v:
Case Reports in Pulmonology, Vol 2017 (2017)
Bronchus Associated Lymphoid Tissue Lymphoma (BALTOMA) is a rare subgroup of pulmonary non-Hodgkin’s lymphomas (NHLs) comprising less than 1% of all cases. It constitutes 3.6% of all extranodal lymphomas and only 0.5–1% of primary pulmonary malig
Externí odkaz:
https://doaj.org/article/e1f6c583a87e433585555fe35167280b
Autor:
Özden ÖZLÜK, Mustafa Murat ÖZBALAK, Tarık Onur TİRYAKİ, Sevgi KALAYOĞLU BEŞIŞIK, Tuba SARAÇ SİVRİKOZ
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S40- (2021)
Objective: Glanzmann thrombasthenia (GT) is a hereditary bleeding disorder. The platelets lack αIIbβ3integrin and fail to aggregate. Pregnancy can also lead to isoantibody formation when fetal cells with β3integrins pass into the circulation of a
Externí odkaz:
https://doaj.org/article/c2b4b3726a1445d88f9a5b5bd19c070b